HARVEY CAPITAL MANAGEMENT INC HALO Holdings History
HARVEY CAPITAL MANAGEMENT INC's Halozyme Therapeutics Inc Holding Summary
As of 2025-03-31, HARVEY CAPITAL MANAGEMENT INC held 149,175.00 shares of Halozyme Therapeutics Inc(HALO), totaling $9.52 Mil. This investment constitutes 2.49% of their stock portfolio, and HARVEY CAPITAL MANAGEMENT INC now holds 0.12% of the outstanding Halozyme Therapeutics Inc(HALO) stock.
The initial trade took place in 2014Q1. And since then HARVEY CAPITAL MANAGEMENT INC has made 5 purchases of HALO, at an average price of $17.45, for a total of 926,640.00 shares. In addition, there have been 8 sales at an average price of $11.81 for 777,465.00 shares. Based on historical transaction data and HALO's current price of $58.77, HARVEY CAPITAL MANAGEMENT INC's estimated gain on his HALO holdings is $1.78 Mil, reflecting a 11.03% gain to date.
HARVEY CAPITAL MANAGEMENT INC HALO ($58.77) Holding Chart
HARVEY CAPITAL MANAGEMENT INC HALO ($58.77) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
